The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Resistance to Antibiotics Mediated by Target Alterations
Abstract
The development of resistance to antibiotics by reductions in the affinities of their enzymatic targets occurs most rapidly for antibiotics that inactivate a single target and that are not analogs of substrate. In these cases of resistance (for example, resistance to rifampicin), numerous single amino acid substitutions may provide large decreases in the affinity of the target for the antibiotic, leading to clinically significant levels of resistance. Resistance due to target alterations should occur much more slowly for those antibiotics (penicillin, for example) that inactivate multiple targets irreversibly by acting as close analogs of substrate. Resistance to penicillin because of target changes has emerged, by unexpected mechanisms, only in a limited number of species. However, inactivating enzymes commonly provide resistance to antibiotics that, like penicillin, are derived from natural products, although such enzymes have not been found for synthetic antibiotics. Thus, the ideal antibiotic would be produced by rational design, rather than by the modification of a natural product.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The crisis in antibiotic resistance
Neu, H. C. (1992) · Science · doi:10.1126/science.257.5073.1064 · Cited by 2,834
Smith, J. M., Smith, N. H., O'Rourke, M., & Spratt, B. G. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.10.4384 · Cited by 1,802
Self-citationInactivation of Antibiotics and the Dissemination of Resistance Genes
Davies, J. (1994) · Science · doi:10.1126/science.8153624 · Cited by 1,730
Prevention of Drug Access to Bacterial Targets: Permeability Barriers and Active Efflux
Nikaido, H. (1994) · Science · doi:10.1126/science.8153625 · Cited by 1,540
Structure-Based Strategies for Drug Design and Discovery
Kuntz, I. D. (1992) · Science · doi:10.1126/science.257.5073.1078 · Cited by 989
Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli
Yoshida, H., Bogaki, M., Nakamura, M., Yamanaka, L. M., & Nakamura, S. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.8.1647 · Cited by 777
Rayssiguier, C., Thaler, D. S., & Radman, M. (1989) · Nature · doi:10.1038/342396a0 · Cited by 721
Jin, D. J., & Gross, C. A. (1988) · Journal of Molecular Biology · doi:10.1016/0022-2836(88)90517-7 · Cited by 683
SERINE β-LACTAMASES AND PENICILLIN-BINDING PROTEINS
Ghuysen, J.-M. (1991) · Annual Review of Microbiology · doi:10.1146/annurev.mi.45.100191.000345 · Cited by 628
Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli
Yoshida, H., Bogaki, M., Nakamura, M., & Nakamura, S. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.6.1271 · Cited by 570
The Ribosome : structure, function, and evolution
Hill, W. E. (1990) · Medical Entomology and Zoology · Cited by 521
Benveniste, R., & Davies, J. (1973) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.70.8.2276 · Cited by 507
Dowson, C. G., Hutchison, A., Brannigan, J. A., George, R. C., Hansman, D., Liñares, J., Tomasz, A., Smith, J. M., & Spratt, B. G. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.22.8842 · Cited by 404
Self-citationNew Mechanisms of Bacterial Resistance to Antimicrobial Agents
Epstein, F. H., Jacoby, G. A., & Archer, G. L. (1991) · New England Journal of Medicine · doi:10.1056/nejm199102283240906 · Cited by 312
Song, M. D., Wachi, M., Doi, M., Ishino, F., & Matsuhashi, M. (1987) · FEBS Letters · doi:10.1016/0014-5793(87)80373-3 · Cited by 302
Laible, G., Spratt, B. G., & Hakenbeck, R. (1991) · Molecular Microbiology · doi:10.1111/j.1365-2958.1991.tb00821.x · Cited by 277
Self-citationSpratt, B., Bowler, L., Zhang, Q.-Y., Zhou, J., & Smith, J. (1992) · Journal of Molecular Evolution · doi:10.1007/bf00182388 · Cited by 270
Self-citationDowson, C. G., Coffey, T. J., Kell, C., & Whiley, R. A. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb01723.x · Cited by 259
Hybrid penicillin-binding proteins in penicillin-resistant strains of Neisseria gonorrhoeae
Spratt, B. G. (1988) · Nature · doi:10.1038/332173a0 · Cited by 253
Self-citationDiscovery and development of new antibiotics: the problem of antibiotic resistance
Silver, L. L., & Bostian, K. A. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.3.377 · Cited by 253
Telenti, A., Imboden, P., Marchesi, F., Schmidheini, T., & Bodmer, T. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.10.2054 · Cited by 250
Bradley, J. S., & Connor, J. D. (1991) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199111000-00018 · Cited by 238
Musser, J. M., & Kapur, V (1992) · Journal of Clinical Microbiology · doi:10.1128/jcm.30.8.2058-2063.1992 · Cited by 231
Penicillin-Binding Proteins of Gram-Negative Bacteria
Spratt, B. G., & Cromie, K. D. (1988) · Clinical Infectious Diseases · doi:10.1093/clinids/10.4.699 · Cited by 217
Self-citationBradley, J. S., & Connor, J. D. (1991) · PubMed · Cited by 217
Bowler, L. D., Zhang, Q. Y., Riou, J. Y., & Spratt, B. G. (1994) · Journal of Bacteriology · doi:10.1128/jb.176.2.333-337.1994 · Cited by 208
Self-citationCOMFREY HERB TEA AND HEPATIC VENO-OCCLUSIVE DISEASE
Ridker, P., & Mcdermott, W. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92154-5 · Cited by 206
Severinov, K., Soushko, M., Goldfarb, A., & Nikiforov, V. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82407-3 · Cited by 203
Dowson, C. G., Hutchison, A., Woodford, N., Johnson, A. P., George, R. C., & Spratt, B. G. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.15.5858 · Cited by 202
Self-citationMolecular basis of rifampin resistance in Mycobacterium leprae
Honore, N., & Cole, S. T. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.3.414 · Cited by 198
Spratt, B. G., Zhang, Q. Y., Jones, D. M., Hutchison, A., Brannigan, J. A., & Dowson, C. G. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.22.8988 · Cited by 197
Self-citationMuñoz, R., Dowson, C. G., Daniels, M., Coffey, T. J., Martin, C., Hakenbeck, R., & Spratt, B. G. (1992) · Molecular Microbiology · doi:10.1111/j.1365-2958.1992.tb01422.x · Cited by 193
Self-citationSreedharan, S., Oram, M., Jensen, B., Peterson, L. R., & Fisher, L. M. (1990) · Journal of Bacteriology · doi:10.1128/jb.172.12.7260-7262.1990 · Cited by 173
The molecular basis of quinolone action
MAXWELL, A. (1992) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/30.4.409 · Cited by 167
Ryffel, C., Tesch, W., Birch-Machin, I., Reynolds, P. E., Barberis-Maino, L., Kayser, F. H., & Berger-Bächi, B. (1990) · Gene · doi:10.1016/0378-1119(90)90481-6 · Cited by 166
Dowson, C. G., Hutchison, A., & Spratt, B. G. (1989) · Molecular Microbiology · doi:10.1111/j.1365-2958.1989.tb00108.x · Cited by 155
Self-citationSáez-Nieto, J. A., Lujan, R., Berrón, S., Campos, J., Viñas, M., Fusté, C., Vázquez, J. A., Zhang, Q. Y., Bowler, L. D., Martı́nez-Suárez, J. V., et al. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.2.394 · Cited by 139
Self-citationMartin, C., Sibold, C., & Hakenbeck, R. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05475.x · Cited by 105
Brannigan, J. A., Tirodimos, I., Zhang, Q. ‐., Dowson, C. G., & Spratt, B. G. (1990) · Molecular Microbiology · doi:10.1111/j.1365-2958.1990.tb00664.x · Cited by 100
Self-citationInteraction of Non-lytic -Lactams with Penicillin-binding Proteins in Streptococcus pneumoniae
Hakenbeck, R., Tornette, S., & Adkinson, N. F. (1987) · Microbiology · doi:10.1099/00221287-133-3-755 · Cited by 94
Mendelman, P. M., Campos, J., Chaffin, D. O., et al. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.5.706 · Cited by 86
Rådström, P., Fermér, C., Kristiansen, B., Jenkins, A., Sköld, O., & Swedberg, G. (1992) · Journal of Bacteriology · doi:10.1128/jb.174.20.6386-6393.1992 · Cited by 85
Hedge, P., & Spratt, B. G. (1985) · Nature · doi:10.1038/318478a0 · Cited by 70
Self-citationCoffey, T. J., Dowson, C. G., Daniels, M., & Spratt, B. G. (1993) · FEMS Microbiology Letters · doi:10.1016/0378-1097(93)90125-l · Cited by 69
Self-citationInactivation of rifampin by Nocardia brasiliensis
Yazawa, K., Mikami, Y., Maeda, A., Akao, M., Morisaki, N., & Iwasaki, S. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.6.1313 · Cited by 65
Hedge, P., & Spratt, B. G. (1985) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1985.tb09075.x · Cited by 63
Self-citationDAVIES, J. E. (1992) · Journal of General Microbiology · doi:10.1099/00221287-138-8-1553 · Cited by 43
Ribosomal Changes Resulting in Antimicrobial Resistance
Hummel, H. S., & Böck, A. (1989) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-74095-4_9 · Cited by 5
Cited by
Antibacterial resistance worldwide: causes, challenges and responses
Levy, S. B., & Marshall, B. (2004) · Nature Medicine · doi:10.1038/nm1145 · Cited by 4,052
Multidrug Resistance in Bacteria
Nikaido, H. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.78.082907.145923 · Cited by 1,682
Characterization of the action of selected essential oil components on Gram-negative bacteria
Helander, I. M., Alakomi, H.-L., Latva-Kala, K., Mattila-Sandholm, T., Pol, I., Smid, E. J., Gorris, L. G. M., & von Wright, A. (1998) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf980154m · Cited by 1,664
Molecular mechanisms that confer antibacterial drug resistance
Walsh, C. (2000) · Nature · doi:10.1038/35021219 · Cited by 1,578
Prevention of Drug Access to Bacterial Targets: Permeability Barriers and Active Efflux
Nikaido, H. (1994) · Science · doi:10.1126/science.8153625 · Cited by 1,540
Metadata
- Authors
- Spratt, B. G.
- Venue
- Science
- Published
- 1994-04-15
- Volume
- 264
- Issue
- 5157
- Pages
- 388-393
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2082064308
- Cited by
- 674
- References
- 48
- FWCI
- 18.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.